Ten-year adjuvant hormone therapy for breast cancer: the pros and cons (a review of literature)

Tamoxifen is one of the basic drugs of adjuvant hormone therapy in patients with hormone-dependent breast tumors. The purpose of this paper is to analyze the results of randomized trials of long-term adjuvant hormone therapy for breast cancer.

Saved in:
Bibliographic Details
Main Authors: S. M. Portnoy (Author), T. A. Shendrikova (Author)
Format: Book
Published: ABV-press, 2014-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available